Incannex Healthcare Limited - ADR
Incannex Healthcare Limited - ADR Stock, NASDAQ:IXHL
Incannex Healthcare Ltd. is a cannabinoid and psychedelic compound medicine development company. It develops targeted and scientifically validated fixed-dose combinations of synthetic cannabinoid and psychedelic agents, applying proprietary insights in an effort to create long term value for its patients and shareholders. The firm focuses on clinical indications that represents unmet or inadequately addressed medical needs and also represents compelling commercial opportunities. The company was founded on April 27, 2001 and is headquartered in Melbourne, Australia.